Dexcom acquires Nutrisense and unveils enhanced Stelo app, expanding focus beyond glucose monitoring –
Acquisition adds nutrition coaching and dietitian support; redesigned Stelo app introduces AI-powered metabolic health insights
Dexcom announced today that it has entered into an agreement to acquire metabolic health platform Nutrisense for an undisclosed amount and simultaneously unveiled a redesigned experience for its Stelo over-the-counter CGM application. Together, the announcements signal Dexcom’s continued push beyond traditional glucose monitoring toward a broader metabolic health ecosystem that includes glucose insights, nutrition guidance, behavior change, and preventative care.
The company said the Nutrisense acquisition is expected to close in the coming weeks, while the updated Stelo application, which received FDA clearance last month, will enter limited early access at ADA 2026 ahead of a broader commercial launch later this summer.
Nutrisense acquisition expands Dexcom’s nutrition and coaching capabilities
Chicago-based Nutrisense, founded in 2019, combines CGM data with registered dietitian support, personalized nutrition guidance, and behavior-change coaching. The platform is designed to help users understand how food choices and daily behaviors influence glucose patterns and broader metabolic health.
Through the acquisition, Dexcom gains access to a coaching infrastructure. Nutrisense also incorporates AI tools that identify behavioral and metabolic patterns over time, helping dietitians provide more personalized recommendations.
Redesigned Stelo app introduces AI coaching and personalized metabolic insights
Alongside the acquisition announcement, Dexcom revealed a substantially redesigned Stelo application. The company said the new experience will incorporate:
- AI-powered coaching and guidance;
- Personalized metabolic summaries; and
- Pattern recognition and behavioral insights.
The redesign builds upon AI meal-logging features introduced earlier this year and appears intended to make glucose information more actionable for users without requiring deep interpretation of CGM data.
ADA 2026 expected to showcase Dexcom’s broader metabolic health ecosystem
Today's announcement closely aligns with themes Dexcom highlighted during its recent Investor Day, where management emphasized expanding CGM adoption beyond intensive insulin users and into earlier-stage T2D, metabolic health, wellness, and prevention-oriented populations. With ADA 2026 beginning tomorrow, Dexcom is expected to further highlight this strategy through the CONNECT study results in people with T2D not using insulin, the redesigned Stelo app, and the newly announced Nutrisense acquisition.
Dexcom also said it plans to offer select users early access to the updated Stelo experience during ADA ahead of broader launch later this summer, though details on user selection have not yet been shared.
Close Concerns’ Questions
- How does Dexcom envision balancing AI-generated coaching with human dietitian support over time?
- How will users be selected for early access to the redesigned Stelo application, and what feedback is Dexcom hoping to gather during the limited rollout?
- How will Dexcom differentiate Stelo from competing metabolic health platforms that incorporate CGM data and coaching?
- Will Nutrisense services eventually be offered within Stelo or will the platform continue to operate independently?
--by Riya Chatterjee, Jeremy Alkire, Monica Oxenreiter, and Kelly Close